Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

High-throughput screening for the identification of new therapeutic options for metastatic pheochromocytoma and paraganglioma

A. Giubellino, U. Shankavaram, P. Bullova, J. Schovanek, Y. Zhang, M. Shen, N. Patel, A. Elkahloun, MJ. Lee, J. Trepel, M. Ferrer, K. Pacak,

. 2014 ; 9 (4) : e90458.

Language English Country United States

Document type Journal Article, Research Support, N.I.H., Intramural

Persistent link   https://www.medvik.cz/link/bmc15014429

Drug repurposing or repositioning is an important part of drug discovery that has been growing in the last few years for the development of therapeutic options in oncology. We applied this paradigm in a screening of a library of about 3,800 compounds (including FDA-approved drugs and pharmacologically active compounds) employing a model of metastatic pheochromocytoma, the most common tumor of the adrenal medulla in children and adults. The collection of approved drugs was screened in quantitative mode, testing the compounds in compound-titration series (dose-response curves). Analysis of the dose-response screening data facilitated the selection of 50 molecules with potential bioactivity in pheochromocytoma cells. These drugs were classified based on molecular/cellular targets and signaling pathways affected, and selected drugs were further validated in a proliferation assay and by flow cytometric cell death analysis. Using meta-analysis information from molecular targets of the top drugs identified by our screening with gene expression data from human and murine microarrays, we identified potential drugs to be used as single drugs or in combination. An example of a combination with a synergistic effect is presented. Our study exemplifies a promising model to identify potential drugs from a group of clinically approved compounds that can more rapidly be implemented into clinical trials in patients with metastatic pheochromocytoma or paraganglioma.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15014429
003      
CZ-PrNML
005      
20150421092155.0
007      
ta
008      
150420s2014 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1371/journal.pone.0090458 $2 doi
035    __
$a (PubMed)24699253
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Giubellino, Alessio $u Program in Reproductive and Adult Endocrinology, Eunice Kennedy Shriver National Institute of Child Health & Human Development, NIH, Bethesda, Maryland, United States of America.
245    10
$a High-throughput screening for the identification of new therapeutic options for metastatic pheochromocytoma and paraganglioma / $c A. Giubellino, U. Shankavaram, P. Bullova, J. Schovanek, Y. Zhang, M. Shen, N. Patel, A. Elkahloun, MJ. Lee, J. Trepel, M. Ferrer, K. Pacak,
520    9_
$a Drug repurposing or repositioning is an important part of drug discovery that has been growing in the last few years for the development of therapeutic options in oncology. We applied this paradigm in a screening of a library of about 3,800 compounds (including FDA-approved drugs and pharmacologically active compounds) employing a model of metastatic pheochromocytoma, the most common tumor of the adrenal medulla in children and adults. The collection of approved drugs was screened in quantitative mode, testing the compounds in compound-titration series (dose-response curves). Analysis of the dose-response screening data facilitated the selection of 50 molecules with potential bioactivity in pheochromocytoma cells. These drugs were classified based on molecular/cellular targets and signaling pathways affected, and selected drugs were further validated in a proliferation assay and by flow cytometric cell death analysis. Using meta-analysis information from molecular targets of the top drugs identified by our screening with gene expression data from human and murine microarrays, we identified potential drugs to be used as single drugs or in combination. An example of a combination with a synergistic effect is presented. Our study exemplifies a promising model to identify potential drugs from a group of clinically approved compounds that can more rapidly be implemented into clinical trials in patients with metastatic pheochromocytoma or paraganglioma.
650    _2
$a nádory nadledvin $x farmakoterapie $x genetika $x patologie $7 D000310
650    _2
$a dospělí $7 D000328
650    _2
$a zvířata $7 D000818
650    _2
$a protinádorové látky $x farmakologie $7 D000970
650    _2
$a western blotting $7 D015153
650    _2
$a proliferace buněk $x účinky léků $7 D049109
650    12
$a objevování léků $7 D055808
650    12
$a přehodnocení terapeutických indikací léčivého přípravku $7 D058492
650    _2
$a průtoková cytometrie $7 D005434
650    _2
$a stanovení celkové genové exprese $7 D020869
650    12
$a rychlé screeningové testy $7 D057166
650    _2
$a lidé $7 D006801
650    _2
$a myši $7 D051379
650    _2
$a sekvenční analýza hybridizací s uspořádaným souborem oligonukleotidů $7 D020411
650    _2
$a paragangliom $x farmakoterapie $x genetika $x patologie $7 D010235
650    _2
$a feochromocytom $x farmakoterapie $x genetika $x sekundární $7 D010673
650    _2
$a messenger RNA $x genetika $7 D012333
650    _2
$a kvantitativní polymerázová řetězová reakce $7 D060888
650    _2
$a polymerázová řetězová reakce s reverzní transkripcí $7 D020133
650    _2
$a signální transdukce $7 D015398
650    _2
$a nádorové biomarkery $x genetika $x metabolismus $7 D014408
655    _2
$a časopisecké články $7 D016428
655    _2
$a Research Support, N.I.H., Intramural $7 D052060
700    1_
$a Shankavaram, Uma $u Radiation Oncology Branch, National Cancer Institute, NIH, Bethesda, Maryland, United States of America.
700    1_
$a Bullova, Petra $u Program in Reproductive and Adult Endocrinology, Eunice Kennedy Shriver National Institute of Child Health & Human Development, NIH, Bethesda, Maryland, United States of America; Department of Molecular Medicine, Institute of Virology, Slovak Academy of Sciences, Bratislava, Slovak Republic.
700    1_
$a Schovanek, Jan $u Program in Reproductive and Adult Endocrinology, Eunice Kennedy Shriver National Institute of Child Health & Human Development, NIH, Bethesda, Maryland, United States of America; Department of Internal Medicine III - Nephrology, Rheumatology and Endocrinology, University Hospital of Olomouc, Czech Republic.
700    1_
$a Zhang, Yaqin $u National Center for Advancing Translational Sciences, NIH, Rockville, Maryland, United States of America.
700    1_
$a Shen, Min $u National Center for Advancing Translational Sciences, NIH, Rockville, Maryland, United States of America.
700    1_
$a Patel, Nikita $u Program in Reproductive and Adult Endocrinology, Eunice Kennedy Shriver National Institute of Child Health & Human Development, NIH, Bethesda, Maryland, United States of America.
700    1_
$a Elkahloun, Abdel $u National Human Genome Research Institute, NIH, Bethesda, Maryland, United States of America.
700    1_
$a Lee, Min-Jung $u Medical Oncology Branch, National Cancer Institute, NIH, Bethesda, Maryland, United States of America.
700    1_
$a Trepel, Jane $u Medical Oncology Branch, National Cancer Institute, NIH, Bethesda, Maryland, United States of America.
700    1_
$a Ferrer, Marc $u National Center for Advancing Translational Sciences, NIH, Rockville, Maryland, United States of America.
700    1_
$a Pacak, Karel $u Program in Reproductive and Adult Endocrinology, Eunice Kennedy Shriver National Institute of Child Health & Human Development, NIH, Bethesda, Maryland, United States of America.
773    0_
$w MED00180950 $t PloS one $x 1932-6203 $g Roč. 9, č. 4 (2014), s. e90458
856    41
$u https://pubmed.ncbi.nlm.nih.gov/24699253 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20150420 $b ABA008
991    __
$a 20150421092453 $b ABA008
999    __
$a ok $b bmc $g 1072010 $s 897307
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 9 $c 4 $d e90458 $i 1932-6203 $m PLoS One $n PLoS One $x MED00180950
LZP    __
$a Pubmed-20150420

Find record

Citation metrics

Archiving options